single gNO injection
Showing 1 - 25 of >10,000
Cancer Trial (Nitric Oxide 25,000 ppm, Nitric Oxide 50,000 ppm, Nitric Oxide 100,000 ppm)
Not yet recruiting
- Cancer
- Nitric Oxide 25,000 ppm
- +3 more
- (no location specified)
Apr 25, 2022
Adult Trial in Zhengzhou (GT101)
Recruiting
- Adult
- GT101
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Oct 11, 2023
Anesthesia Trial (Single injection supraclavicular nerve block, Double injection supraclavicular nerve block)
Withdrawn
- Anesthesia
- Single injection supraclavicular nerve block
- Double injection supraclavicular nerve block
- (no location specified)
Nov 10, 2022
Acromegaly Trial in Beijing (SYHX2008 injection, Octreotide Acetate Microspheres for Injection injection, Sandostatin ®
Recruiting
- Acromegaly
- SYHX2008 injection
- +3 more
-
Beijing, Beijing, ChinaBeijing Anzhen Hospital, Capital Medical University
Mar 13, 2023
Healthy Trial in Sichuan (THDB0206 injection, Humalog®, BC222insulin lispro injection)
Completed
- Healthy
- THDB0206 injection
- +2 more
-
Sichuan, ChinaWest China Hospital of Sichuan University
Nov 22, 2023
Post Operative Pain, Regional Block Trial in Minya (single level, dual level)
Recruiting
- Post Operative Pain
- Regional Block
- single level
- dual level
-
Minya, Minia, EgyptMinia University
Dec 7, 2022
Anesthesia, Local Trial in Baghdad (Maxillary extraction without palatal injection, Maxillary extraction with buccal and palatal
Active, not recruiting
- Anesthesia, Local
- Maxillary extraction without palatal injection
- Maxillary extraction with buccal and palatal injection
-
Baghdad, Almansour, IraqAlmustafa Qays
Jul 16, 2023
Diabetes Trial in Chengdu (INS062 injection, Insulin Aspart, HR20014 injection)
Recruiting
- Diabetes
- INS062 injection
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Feb 8, 2023
Metastatic Breast Cancer Trial in Amman (Fulvestrant injection)
Completed
- Metastatic Breast Cancer
- Fulvestrant injection
-
Amman, JordanTriumpharma Cro
Oct 3, 2023
Diabetes, Type 2 Trial in Changchun (AP026 (TQA2226) for injection, AP026 (TQA2226) for injection matching )
Recruiting
- Diabetes Mellitus, Type 2
- AP026 (TQA2226) for injection
- AP026 (TQA2226) for injection matching placebo
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Nov 16, 2023
Single Injection of Faricimab for nAMD With Persisting Fluid
Active, not recruiting
- Neovascular Age-related Macular Degeneration
-
Glostrup, DenmarkMiklos Schneider
Nov 3, 2023
Subcostal Transversus Abdominis Plane Block Trial in I?stanbul (Single injection subcostal transversus abdominis plane block,
Recruiting
- Subcostal Transversus Abdominis Plane Block
- Single injection subcostal transversus abdominis plane block
- Multiple injection subcostal transversus abdominis plane block
-
İ̇stanbul, Turkey
- +1 more
Apr 12, 2023
Anesthesia, Local Trial in Roskilde (Ropivacaine injection)
Recruiting
- Anesthesia, Local
- Ropivacaine injection
-
Roskilde, Zealand Region, DenmarkDepartment of Anaesthesiology and Intensive Care Medicine, Zeala
Feb 28, 2023
Thoracic Surgery, Video-Assisted, Cryotherapy Effect Trial (Cryoanalgesia AND single-injection paravertebral block,
Not yet recruiting
- Thoracic Surgery
- +3 more
- Cryoanalgesia AND single-injection paravertebral block
- Single-injection paravertebral block
- (no location specified)
Jun 7, 2023
Asthma Trial in Beijing (GR2002 injection, Placebo)
Recruiting
- Asthma
- GR2002 injection
- Placebo
-
Beijing, ChinaPeking University People's Hospital
Jul 13, 2023
Healthy Men Trial in Hefei (BAT1806 prefilled subcutaneous injection/RoActemra® (from EU))
Not yet recruiting
- Healthy Men
- BAT1806 prefilled subcutaneous injection/RoActemra® (from EU)
-
Hefei, Anhui, ChinaThe Second Affiliated Hospital of Anhui Medical University
Jul 27, 2023
Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)
Enrolling by invitation
- Malignant Melanomas
- Recombinant Human Adenovirus Type 5 Injection
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023
Pain Due to Certain Specified Procedures Trial in Giza (infromedial single injection)
Recruiting
- Pain Due to Certain Specified Procedures
- infromedial single injection
- medial canthus injection
-
Giza, Egypt
- +1 more
Sep 16, 2022
Cryotherapy Effect, Chronic Pain, Lung Cancer Trial (Cryoanalgesia AND single-injection paravertebral block, Single-injection
Not yet recruiting
- Cryotherapy Effect
- +3 more
- Cryoanalgesia AND single-injection paravertebral block
- Single-injection paravertebral block
- (no location specified)
May 30, 2023
Magnetic Resonance Imaging Trial in Xinxiang (polysaccharide superparamagnetic iron oxide injection)
Completed
- Magnetic Resonance Imaging
- polysaccharide superparamagnetic iron oxide injection
-
Xinxiang, Henan, ChinaXinxiang Central Hospital
Aug 23, 2023
Diabetes Trial (INS062 injection?INS068 injection?HR20014 injection)
Not yet recruiting
- Diabetes
- INS062 injection、INS068 injection、HR20014 injection
- (no location specified)
May 24, 2023
Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- STSA-1301 subcutaneous injection
- Placebo
-
Beijing, Chaoyang District, ChinaBeijing Ditan Hospital,Capital Medical University
Nov 28, 2023
Bioequivalence Trial in Haikou (Amphotericin B liposome for injection, AmBisome)
Active, not recruiting
- Bioequivalence
- Amphotericin B liposome for injection
- AmBisome
-
Haikou, Hainan, ChinaHaikou people's Hospital
Jun 12, 2023
Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])
Completed
- Gastric Cancer
- +2 more
- Ramucirumab Injection
- Ramucirumab Injection [Cyramza]
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 24, 2023
Adult Patients With Diagnosed Relapsed or Refractory B-cell Lymphoma Who Have Completed Their First Treatment With Regiorense
Recruiting
- Adult Patients With Diagnosed Relapsed or Refractory B-cell Lymphoma Who Have Completed Their First Treatment With Regiorense Injection
- Relmacabtagene Autoleucel Injection
-
Shanghai, Shanghai, ChinaNO.197, Ruijin Er Road
Mar 28, 2023